Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pasithea Therapeutics Corp. - Common Stock (NQ:KTTA)

0.9246 -0.0314 (-3.28%)
Streaming Delayed Price Updated: 10:29 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 197,130
Open 0.9148
Bid (Size) 0.9247 (1)
Ask (Size) 0.9299 (1)
Prev. Close 0.9560
Today's Range 0.9020 - 0.9300
52wk Range 0.7970 - 7.500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Theriva Biologics Shares Plunge After Pricing $7.5M Offering: Retail Sentiment Still Strong
The offering comes on the heels of encouraging data from the Virage Phase 2b trial, which demonstrated significant improvements in overall survival and duration of response for patients receiving... 
Via Stocktwits
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga

Performance

YTD
-68.4%
-68.4%
1 Month
-35.3%
-35.3%
3 Month
-32.5%
-32.5%
6 Month
-71.1%
-71.1%
1 Year
-86.1%
-86.1%

More News

Read More
Wednesday's session: top gainers and losers
Via Chartmill
Which stocks are most active on Tuesday?
Via Chartmill
Pasithea Therapeutics Stock Soars After Positive Data From Cancer Drug Trial: Retail’s Elated
Via Stocktwits
Topics Government
Exposures Political
Pasithea Therapeutics Drug Shows Tumor Reduction In Pancreatic Cancer, Strong Early Trial Results
Via Benzinga
What's going on in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Pasithea Therapeutics Leads Healthcare Buzz Surge As Cancer Trial Clears Safety Hurdle, Moves To Next Dosing Cohort
Via Stocktwits
Top stock movements in today's session.
Via Chartmill
Most active stocks in Thursday's session
Via Chartmill
Top movers analysis in the middle of the day on 2025-04-10: top gainers and losers in today's session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump
Via Benzinga
Exposures Fossil Fuels
Which stocks are moving before the opening bell on Thursday?
Via Chartmill
Dow Tumbles Over 800 Points; US Inflation Rate Falls In March
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Thursday's session: top gainers and losers
Via Chartmill
Thursday's session: gap up and gap down stocks
Via Chartmill
Which stocks are moving before the opening bell on Thursday?
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
These stocks are moving in today's after hours session
Via Chartmill

Frequently Asked Questions

Is Pasithea Therapeutics Corp. - Common Stock publicly traded?
Yes, Pasithea Therapeutics Corp. - Common Stock is publicly traded.
What exchange does Pasithea Therapeutics Corp. - Common Stock trade on?
Pasithea Therapeutics Corp. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pasithea Therapeutics Corp. - Common Stock?
The ticker symbol for Pasithea Therapeutics Corp. - Common Stock is KTTA on the Nasdaq Stock Market
What is the current price of Pasithea Therapeutics Corp. - Common Stock?
The current price of Pasithea Therapeutics Corp. - Common Stock is 0.9246
When was Pasithea Therapeutics Corp. - Common Stock last traded?
The last trade of Pasithea Therapeutics Corp. - Common Stock was at 05/19/25 10:29 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.